Insider Transactions in Q1 2023 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2023
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,647
+18.0%
|
-
|
|
Jan 04
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-1.91%
|
$180,000
$18.1 P/Share
|
|
Jan 04
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.85%
|
$20,000
$2.06 P/Share
|
|
Jan 03
2023
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,187
+24.84%
|
-
|
|
Jan 03
2023
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,187
+26.1%
|
-
|
|
Jan 03
2023
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,187
+36.43%
|
-
|
|
Jan 03
2023
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,187
+24.36%
|
-
|
|
Jan 03
2023
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,187
+26.44%
|
-
|
|
Jan 03
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
99,038
+17.82%
|
-
|
|
Jan 03
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,295
+30.29%
|
-
|
|
Jan 03
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
21,222
+26.26%
|
-
|
|
Jan 03
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,939
+7.11%
|
-
|
|
Jan 03
2023
|
Marcus Schulz Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,733
+20.89%
|
-
|
|
Jan 03
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,978
+11.98%
|
-
|
|
Jan 03
2023
|
Todd Berard Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,885
+9.06%
|
-
|
|
Jan 03
2023
|
Sarah Aebersold Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,450
+21.85%
|
-
|
|
Jan 03
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-1.91%
|
$180,000
$18.26 P/Share
|
|
Jan 03
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.85%
|
$20,000
$2.06 P/Share
|